Publicacións (22) Publicacións de Elena María Brozos Vázquez

2024

  1. Improvement of thrombosis management in patients with cancer: a practical consensus document of recommendations for cancer-associated thrombosis patients’ healthcare in Spain

    Clinical and Translational Oncology, Vol. 26, Núm. 6, pp. 1319-1328

  2. Pancreatic cancer biomarkers: A pathway to advance in personalized treatment selection

    Cancer Treatment Reviews, Vol. 125

  3. Update on the management of older patients with pancreatic adenocarcinoma: a perspective from medical oncology

    Clinical and Translational Oncology

  4. Validation of the CoVID-TE model as a tool to predict thrombosis, bleeding, and mortality in the oncology patient with Sars-Cov-2 infection: a study by the SEOM cancer and thrombosis group

    Clinical and Translational Oncology, Vol. 26, Núm. 1, pp. 171-177

2023

  1. Clinicopathological Profiles Associated with Discordant RAS Mutational Status between Liquid and Tissue Biopsies in a Real-World Cohort of Metastatic Colorectal Cancer

    Cancers, Vol. 15, Núm. 14

  2. Immunotherapy in patients with brain metastasis: advances and challenges for the treatment and the application of circulating biomarkers

    Frontiers in Immunology, Vol. 14

2022

  1. A genome-wide cell-free DNA methylation analysis identifies an episignature associated with metastatic luminal B breast cancer

    Frontiers in Cell and Developmental Biology, Vol. 10

  2. Clinical significance of baseline Pan-Immune-Inflammation Value and its dynamics in metastatic colorectal cancer patients under first-line chemotherapy

    Scientific Reports, Vol. 12, Núm. 1

  3. Effective optimisation of the patient circuits of an oncology day hospital: Mathematical programming models and case study

    Mathematics, Vol. 10, Núm. 1

  4. Noninvasive early detection of colorectal cancer by hypermethylation of the LINC00473 promoter in plasma cell-free DNA

    Clinical Epigenetics, Vol. 14, Núm. 1

  5. Venous Thromboembolism In Cancer Patients: “From Evidence to Care”

    Clinical and Applied Thrombosis/Hemostasis, Vol. 28

2021

  1. Correction to: SEOM clinical guidelines for anaemia treatment in cancer patients (2020) (Clinical and Translational Oncology, (2021), 23, 5, (931-939), 10.1007/s12094-021-02580-2)

    Clinical and Translational Oncology

  2. Direct oral anticoagulants for the treatment and prevention of venous thromboembolism in patients with cancer: current evidence

    Clinical and Translational Oncology, Vol. 23, Núm. 6, pp. 1034-1046

  3. Do clinical trials meet current care needs? Views of digestive oncology specialists in galicia (spain) using the delphi method

    Healthcare (Switzerland), Vol. 9, Núm. 6

  4. Dynamic perspective of the neutrophil-to-lymphocyte ratio in metastatic gastric cancer

    Journal of B.U.ON., Vol. 26, Núm. 5, pp. 2131-2140

  5. Evaluation of a targeted next-generation sequencing panel for the non-invasive detection of variants in circulating dna of colorectal cancer

    Journal of Clinical Medicine, Vol. 10, Núm. 19

  6. Immunotherapy in nonsmall-cell lung cancer: current status and future prospects for liquid biopsy

    Cancer Immunology, Immunotherapy, Vol. 70, Núm. 5, pp. 1177-1188

  7. Molecularly targeted therapy in metastatic CRC

    Foundations of Colorectal Cancer (Elsevier), pp. 357-364

  8. SEOM clinical guidelines for anaemia treatment in cancer patients (2020)

    Clinical and Translational Oncology, Vol. 23, Núm. 5, pp. 931-939

2019

  1. Is there any affordable and reliable score in local gastric cancer?

    Annals of Oncology, Vol. 30, pp. iv60